MedWatch

Coloplast considers increasing tax payment transparency after criticism

Following bouts of criticism from major Danish pension funds, medtech giant Coloplast reviews options for increasing transparency of tax payment.

Coloplast's EVP and CFO Anders Lonning Skovgaard | Photo: Coloplast / PR

A host of pension companies have called for more transparency in tax payments from major Danish companies – including Coloplast – the latter of which will examine the possibility of providing more transparency in the tax payment area, which Coloplast's Executive Vice President and Chief Financial Officer Anders Lonning Skovgaard confirms.

"They are calling for more transparency concerning our taxes, and we are working on exactly that. We're examining how to make our tax payments even more transparent to our stakeholders," the CFO tells MedWatch.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs